<DOC>
	<DOCNO>NCT01264484</DOCNO>
	<brief_summary>The objective study assess long term safety durability Advantage prosthetic heart valve .</brief_summary>
	<brief_title>ADVANTAGEÂ® Prosthetic Heart Valve Long-term Follow-up Trial</brief_title>
	<detailed_description>The objective study assess long term safety durability Advantage prosthetic heart valve patient already implanted device .</detailed_description>
	<mesh_term>Imidacloprid</mesh_term>
	<criteria>Participated ADVANTAGE Prosthetic Heart Valve Study Herz und Diabeteszentrum ( Bad Oeynhausen ) Deutsches Herzzentrum ( Munich ) Signed dated patient data release form Available followup High probability nonadherence physician 's followup requirement</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Advantage</keyword>
	<keyword>Non-interventional</keyword>
	<keyword>Post market release study</keyword>
	<keyword>Germany</keyword>
	<keyword>Treated Advantage prosthetic heart valve</keyword>
</DOC>